The 2nd Edition of the InSciTech Meet on Cell & Gene Therapy (IMCELLGENE2027) is a premier international conference dedicated to showcasing cutting-edge research, clinical advancements, and innovative therapeutic approaches in cell therapy, gene therapy, and regenerative medicine. The summit will be held from April 05–07, 2027, in Tokyo, Japan.

IMCELLGENE2027 will bring together a global community of scientists, clinicians, translational researchers, biotechnologists, academicians, regulatory experts, policymakers, and industry leaders to exchange knowledge, foster collaboration, and advance evidence-based strategies for the development and clinical translation of advanced cell- and gene-based therapies.

Organized by InSciTech Summits, this three-day event offers a multidisciplinary platform for the exchange of pioneering ideas, discussion of real-world preclinical, clinical, and regulatory applications, and development of meaningful collaborations between academia, research institutions, healthcare organizations, and the biotechnology and pharmaceutical industries. The scientific and professional program will feature plenary and keynote lectures, technical sessions, interactive panel discussions, workshops, and extensive networking opportunities, all designed to inspire innovation and accelerate progress in cell and gene therapy research and commercialization.

Market Analysis – IMCELLGENE2027

The global market for cell and gene therapy is experiencing rapid growth, driven by breakthroughs in genome editing technologies, expanding clinical pipelines for rare and chronic diseases, increased investment in regenerative medicine, evolving regulatory frameworks, and growing adoption of personalized and precision medicine approaches.